Product NDC: | 63323-353 |
Proprietary Name: | Cefuroxime |
Non Proprietary Name: | Cefuroxime |
Active Ingredient(s): | 1.5 g/1 & nbsp; Cefuroxime |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-353 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA064125 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110524 |
Package NDC: | 63323-353-45 |
Package Description: | 25 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (63323-353-45) |
NDC Code | 63323-353-45 |
Proprietary Name | Cefuroxime |
Package Description | 25 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (63323-353-45) |
Product NDC | 63323-353 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefuroxime |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110524 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | CEFUROXIME |
Strength Number | 1.5 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |